Skip to content

MAZE MAZE Total Liabilities & Equity

Total Liabilities & Equity at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$26.48B+15.8%
Septerna, Inc. logo
Septerna, Inc.SEPN
$569.69M+31.3%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$443.28M+8.9%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
$530.65M+29.5%
Zymeworks logo
ZymeworksZYME
$478.22M+12.4%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$636.13M+3.4%

Other financials

Income statement

See full
Revenue$20.0M
Operating income-$26.6M+25.0%
Net income-$24.2M+26.2%
EPS (diluted)-$0.45+60.9%

Balance sheet

See full
Cash & equivalents$198.8M-32.5%
Total debt$61.2M+137%
Total equity$341.7M+17.0%
Total assets$419.7M+26.1%

Cash flow

See full
Operating cash flow-$39.1M-32.5%
CapEx$93.0K-68.9%
Free cash flow-$39.2M-31.5%

Valuation

See full
Market cap$1.48B+201%
Enterprise value$1.34B
P/S7.9×

Profitability

See full
Operating margin-71.5%
Net margin-65.4%
FCF margin-65.1%

Returns & leverage

See full
Return on equity-38.7%
Debt / equity0.2×+0.1×
Current ratio17.9×+1.8×

Where this comes from

Reported directly by MAZE in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The official record: MAZE’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about MAZE's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MAZE's total liabilities & equity?
MAZE (MAZE) reported total liabilities & equity of $419.71M in Q1 2026.
How has MAZE's total liabilities & equity changed year-over-year?
MAZE's total liabilities & equity increased by 26.1% year-over-year, from $332.84M to $419.71M.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.